Fingolimod - Latest Advances

Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma.

Journal: Journal of medicinal chemistry

Published: October 17, 2025

Applicability of regenerative oligodendrocyte precursor cell optic nerve transplantation in rat model of demyelinating disease.

Journal: Cell transplantation

Published: October 15, 2025

Human papillomavirus-related conditions in women with multiple sclerosis receiving disease-modifying therapies: A Pharmacovigilance disproportionality analysis from the WHO vigibase®.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 08, 2025

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: September 30, 2025

JC virus PCR assay reporting for PML: promises, perils, and pitfalls.

Journal: Journal of neurology

Published: September 16, 2025

Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.

Journal: JAMA network open

Published: September 15, 2025

Modulation of Paraoxonase 1 Activity and Asymmetric Dimethylarginine by Immunomodulatory Therapies in Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: September 03, 2025

Fingolimod as a Potential Cerebroprotectant Results From the Stroke Preclinical Assessment Network.

Journal: Stroke

Published: September 03, 2025

An autopsy case of primary progressive multiple sclerosis with minimal acute inflammation and remyelination over an 11-year course

Journal: Rinsho shinkeigaku = Clinical neurology

Published: August 27, 2025

Discovery of Novel β-Arrestin Biased Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis.

Journal: Journal of medicinal chemistry

Published: August 25, 2025

EXPRESS: Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression.

Journal: Molecular pain

Published: August 14, 2025

Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression.

Journal: Molecular pain

Published: August 14, 2025

Filters

Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma.

Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma.

Applicability of regenerative oligodendrocyte precursor cell optic nerve transplantation in rat model of demyelinating disease.

Applicability of regenerative oligodendrocyte precursor cell optic nerve transplantation in rat model of demyelinating disease.

Human papillomavirus-related conditions in women with multiple sclerosis receiving disease-modifying therapies: A Pharmacovigilance disproportionality analysis from the WHO vigibase®.

Human papillomavirus-related conditions in women with multiple sclerosis receiving disease-modifying therapies: A Pharmacovigilance disproportionality analysis from the WHO vigibase®.

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

JC virus PCR assay reporting for PML: promises, perils, and pitfalls.

JC virus PCR assay reporting for PML: promises, perils, and pitfalls.

Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.

Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.

Modulation of Paraoxonase 1 Activity and Asymmetric Dimethylarginine by Immunomodulatory Therapies in Multiple Sclerosis.

Modulation of Paraoxonase 1 Activity and Asymmetric Dimethylarginine by Immunomodulatory Therapies in Multiple Sclerosis.

Fingolimod as a Potential Cerebroprotectant Results From the Stroke Preclinical Assessment Network.

Fingolimod as a Potential Cerebroprotectant Results From the Stroke Preclinical Assessment Network.

An autopsy case of primary progressive multiple sclerosis with minimal acute inflammation and remyelination over an 11-year course

An autopsy case of primary progressive multiple sclerosis with minimal acute inflammation and remyelination over an 11-year course

Discovery of Novel β-Arrestin Biased Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis.

Discovery of Novel β-Arrestin Biased Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis.

EXPRESS: Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression.

EXPRESS: Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression.

Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression.

Targeting sphingosine-1-phosphate receptor 1 alleviates neuropathic pain associated with pancreatic ductal adenocarcinoma in mice and inhibits tumor progression.